| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | $0.00 | $4.01M | $18.39M |
| Cost of Revenue | – | – | $0.00 | $651.00K | $5.82M |
| Gross Profit | – | – | $0.00 | $3.36M | $12.57M |
| Operating Expenses | – | $42.47M | $37.51M | $37.85M | $37.66M |
| R&D | $47.39M | $37.76M | $32.85M | $31.54M | $28.27M |
| SG&A | $8.29M | $4.71M | $4.66M | $6.30M | $9.39M |
| Operating Income | -$55.69M | -$42.47M | -$37.51M | -$34.49M | -$25.08M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $235.00K | -$32.00K | $244.00K | -$688.00K | -$8.04M |
| Net Income | -$45.54M | -$38.53M | -$24.56M | -$32.90M | -$17.41M |
| EPS (basic) | -1.4900 | -1.2600 | -0.8100 | -1.0800 | -0.5800 |
| EPS (diluted) | -1.4900 | -1.2600 | -0.8100 | -1.0800 | -0.5800 |
| Shares (diluted) | $30.49M | $30.46M | $30.44M | $30.44M | $30.04M |